This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tomkinson, A. Articles by Noble, B. S. Search for Related Content PubMed PubMed Citation Articles by Tomkinson, A. Articles by Noble, B. S. Pubmed/NCBI databases Substance via MeSH

The Death of Osteocytes via Apoptosis Accompanies Estrogen Withdrawal in Human Bone¹

Bone Research Group (Medical Research Council) (B.S.N., A.T., J.R.), Cambridge University Department of Medicine, Addenbrooke’s Hospital, Cambridge, United Kingdom CB2 2QQ; and Department of Obstetrics and Gynecology (R.W.S.), University of Wales Medical College, Cardiff, Wales, United Kingdom

Address all correspondence and requests for reprints to: B. S. Noble, Bone Research Group (Medical Research Council), Cambridge University Department of Medicine, Addenbrooke’s Hospital, Cambridge, United Kingdom CB2 2QQ.

Estrogen withdrawal in women leads initially to rapid bone loss caused by increased numbers or activity of osteoclasts. We previously have noted apoptosis of lacunar osteocytes associated with conditions of high bone turnover. Therefore, in this study, we investigated whether the increased bone loss associated with GnRH analogue (GnRH-a)-induced estrogen withdrawal affects osteocyte viability in situ in a way that would be directly contrary to the effect of estrogens on osteoclast viability.

Transiliac biopsies were obtained from six premenopausal women, between 30–45 yr old, diagnosed as having endometriosis. Biopsies were taken before and after 24 weeks of GnRH-a therapy. Biopsies were snap-frozen and cryostat sectioned. Osteocyte viability, determined by the presence of lactate dehydrogenase (LDH) activity, was reduced in all but one subject after treatment. Furthermore, in every subject, the proportion of osteocytes showing evidence of DNA fragmentation typical of apoptosis increased, as demonstrated using in situ DNA nick translation (P = 0.008). Gel electrophoresis of extracted DNA and morphological studies of chromatin condensation and nuclear fragmentation confirmed that changes typical of apoptosis were affecting the osteocytes.

It was concluded that GnRH-a therapy caused a higher prevalence of dead osteocytes in iliac bone, probably caused by the increase in the observed proportion of osteocytes showing apoptotic changes. The capacity of bone to repair microdamage and to modulate the effects of mechanical strain is currently believed to be dependent on osteocyte viability. Our findings have therefore revealed a possible mechanism whereby estrogen deficiency could lead to increased bone fragility with or without an accompanying net bone loss.

This article has been cited by other articles:

				S. Khosla Estrogen and the Death of Osteoclasts: A Fascinating Story IBMS BoneKEy, October 1, 2007; 4(10): 267 - 272. [Full Text] [PDF]

				M. Almeida, L. Han, M. Martin-Millan, L. I. Plotkin, S. A. Stewart, P. K. Roberson, S. Kousteni, C. A. O'Brien, T. Bellido, A. M. Parfitt, et al. Skeletal Involution by Age-associated Oxidative Stress and Its Acceleration by Loss of Sex Steroids J. Biol. Chem., September 14, 2007; 282(37): 27285 - 27297. [Abstract] [Full Text] [PDF]

				T. Bellido Osteocyte Apoptosis Induces Bone Resorption and Impairs the Skeletal Response to Weightlessness IBMS BoneKEy, September 1, 2007; 4(9): 252 - 256. [Full Text] [PDF]

				J. I. Aguirre, L. I. Plotkin, A. R. Gortazar, M. M. Millan, C. A. O'Brien, S. C. Manolagas, and T. Bellido A Novel Ligand-independent Function of the Estrogen Receptor Is Essential for Osteocyte and Osteoblast Mechanotransduction J. Biol. Chem., August 31, 2007; 282(35): 25501 - 25508. [Abstract] [Full Text] [PDF]

				S. Kaptoge, N. Dalzell, E. Folkerd, D. Doody, K.-T. Khaw, T. J. Beck, N. Loveridge, E. B. Mawer, J. L. Berry, M. J. Shearer, et al. Sex Hormone Status May Modulate Rate of Expansion of Proximal Femur Diameter in Older Women alongside Other Skeletal Regulators J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 304 - 313. [Abstract] [Full Text] [PDF]

				A. J. Chien and P. E. Goss Aromatase Inhibitors and Bone Health in Women With Breast Cancer J. Clin. Oncol., November 20, 2006; 24(33): 5305 - 5312. [Full Text] [PDF]

				S. C. Manolagas Choreography from the Tomb: An Emerging Role of Dying Osteocytes in the Purposeful, and Perhaps Not So Purposeful, Targeting of Bone Remodeling IBMS BoneKEy, January 1, 2006; 3(1): 5 - 14. [Full Text] [PDF]

				L. I. Plotkin, I. Mathov, J. I. Aguirre, A. M. Parfitt, S. C. Manolagas, and T. Bellido Mechanical stimulation prevents osteocyte apoptosis: requirement of integrins, Src kinases, and ERKs Am J Physiol Cell Physiol, September 1, 2005; 289(3): C633 - C643. [Abstract] [Full Text] [PDF]

				Y.-Z. Liu, V. Dvornyk, Y. Lu, H. Shen, J. M. Lappe, R. R. Recker, and H.-W. Deng A Novel Pathophysiological Mechanism for Osteoporosis Suggested by an in Vivo Gene Expression Study of Circulating Monocytes J. Biol. Chem., August 12, 2005; 280(32): 29011 - 29016. [Abstract] [Full Text] [PDF]

				J. D. Veldhuis, J. N. Roemmich, E. J. Richmond, A. D. Rogol, J. C. Lovejoy, M. Sheffield-Moore, N. Mauras, and C. Y. Bowers Endocrine Control of Body Composition in Infancy, Childhood, and Puberty Endocr. Rev., February 1, 2005; 26(1): 114 - 146. [Abstract] [Full Text] [PDF]

				H. W. Goderie-Plomp, M. van der Klift, W. de Ronde, A. Hofman, F. H. de Jong, and H. A. P. Pols Endogenous Sex Hormones, Sex Hormone-Binding Globulin, and the Risk of Incident Vertebral Fractures in Elderly Men and Women: The Rotterdam Study J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3261 - 3269. [Abstract] [Full Text] [PDF]

				H. Sowa, H. Kaji, M. F. Iu, T. Tsukamoto, T. Sugimoto, and K. Chihara Parathyroid Hormone-Smad3 Axis Exerts Anti-apoptotic Action and Augments Anabolic Action of Transforming Growth Factor {beta} in Osteoblasts J. Biol. Chem., December 26, 2003; 278(52): 52240 - 52252. [Abstract] [Full Text] [PDF]

				S. S. Ahuja, S. Zhao, T. Bellido, L. I. Plotkin, F. Jimenez, and L. F. Bonewald CD40 Ligand Blocks Apoptosis Induced by Tumor Necrosis Factor {alpha}, Glucocorticoids, and Etoposide in Osteoblasts and the Osteocyte-Like Cell Line Murine Long Bone Osteocyte-Y4 Endocrinology, May 1, 2003; 144(5): 1761 - 1769. [Abstract] [Full Text] [PDF]

				B. S. Noble, N. Peet, H. Y. Stevens, A. Brabbs, J. R. Mosley, G. C. Reilly, J. Reeve, T. M. Skerry, and L. E. Lanyon Mechanical loading: biphasic osteocyte survival and targeting of osteoclasts for bone destruction in rat cortical bone Am J Physiol Cell Physiol, April 1, 2003; 284(4): C934 - C943. [Abstract] [Full Text] [PDF]

				A. Grey, Q. Chen, K. Callon, X. Xu, I. R. Reid, and J. Cornish The Phospholipids Sphingosine-1-Phosphate and Lysophosphatidic Acid Prevent Apoptosis in Osteoblastic Cells via a Signaling Pathway Involving Gi Proteins and Phosphatidylinositol-3 Kinase Endocrinology, December 1, 2002; 143(12): 4755 - 4763. [Abstract] [Full Text] [PDF]

				D. M. Cooley, B. C. Beranek, D. L. Schlittler, N. W. Glickman, L. T. Glickman, and D. J. Waters Endogenous Gonadal Hormone Exposure and Bone Sarcoma Risk Cancer Epidemiol. Biomarkers Prev., November 1, 2002; 11(11): 1434 - 1440. [Abstract] [Full Text] [PDF]

				S. Khosla, L. J. Melton III, and B. L. Riggs Estrogen and the Male Skeleton J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1443 - 1450. [Abstract] [Full Text] [PDF]

				S.C. Manolagas, S. Kousteni, and R.L. Jilka Sex Steroids and Bone Recent Prog. Horm. Res., January 1, 2002; 57(1): 385 - 409. [Abstract] [Full Text] [PDF]

				D. L. Andress IGF-binding protein-5 stimulates osteoblast activity and bone accretion in ovariectomized mice Am J Physiol Endocrinol Metab, August 1, 2001; 281(2): E283 - E288. [Abstract] [Full Text] [PDF]

				T. S. Gross, N. Akeno, T. L. Clemens, S. Komarova, S. Srinivasan, D. A. Weimer, and S. Mayorov Physiological and Genomic Consequences of Intermittent Hypoxia: Selected Contribution: Osteocytes upregulate HIF-1{alpha} in response to acute disuse and oxygen deprivation J Appl Physiol, June 1, 2001; 90(6): 2514 - 2519. [Abstract] [Full Text] [PDF]

				A. M. Cueto-Manzano, A. J. Freemont, J. E. Adams, B. Mawer, R. Gokal, and A. J. Hutchison Association of sex hormone status with the bone loss of renal transplant patients Nephrol. Dial. Transplant., June 1, 2001; 16(6): 1245 - 1250. [Abstract] [Full Text] [PDF]

				J. E. Compston Sex Steroids and Bone Physiol Rev, January 1, 2001; 81(1): 419 - 447. [Abstract] [Full Text] [PDF]

				S. C. Manolagas Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis Endocr. Rev., April 1, 2000; 21(2): 115 - 137. [Abstract] [Full Text]

				J. S. Dodd, J. A. Raleigh, and T. S. Gross Osteocyte hypoxia: a novel mechanotransduction pathway Am J Physiol Cell Physiol, September 1, 1999; 277(3): C598 - C602. [Abstract] [Full Text] [PDF]

				S. B. Wade, P. Oommen, W. C. Conner, D. J. Earnest, and R. C. Miranda Overlapping and Divergent Actions of Estrogen and the Neurotrophins on Cell Fate and p53-Dependent Signal Transduction in Conditionally Immortalized Cerebral Cortical Neuroblasts J. Neurosci., August 15, 1999; 19(16): 6994 - 7006. [Abstract] [Full Text] [PDF]

				S. R. Cummings, W. S. Browner, D. Bauer, K. Stone, K. Ensrud, S. Jamal, B. Ettinger, and The Study of Osteoporotic Fractures Research Group Endogenous Hormones and the Risk of Hip and Vertebral Fractures among Older Women N. Engl. J. Med., September 10, 1998; 339(11): 733 - 738. [Abstract] [Full Text] [PDF]

				R. Marcus M.D. Editorial: New Perspectives on the Skeletal Role of Estrogen J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2236 - 2238. [Full Text]